Skip to main content
Caplight Logo









StemCardia

StemCardia

Private
Seattle, WashingtonHealthcare & Life Scienceshttps://stemcardia.com

Company Overview

StemCardia operates in Healthcare & Life Sciences and is based in Seattle, Washington. It was founded in 2023.

StemCardia is a biotechnology company that develops cellular and genetic therapies to address heart failure.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

StemCardia Comparables

Compare StemCardia with similar companies based on industry and business-model similarity.

StemCardia comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Heartseed
86%
Help Therapeutics
85%
iHeart Japan Corporation
76%
Book a demo to see all comparables

For institutional investors. Book with your work email.

StemCardia Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for StemCardia. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

StemCardia Filings

Explore SEC and related filing metadata, where available.

StemCardia filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about StemCardia's valuation, stock price, and market status.

Is StemCardia a public or private company?

StemCardia is a private company.

What is the current stock price of StemCardia?

StemCardia is a private company, so its shares have no public market price. Caplight tracks StemCardia's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is StemCardia worth (valuation)?

Valuation information for StemCardia is not publicly available.

Can I buy StemCardia stock?

StemCardia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was StemCardia's last funding round?

Funding round information for StemCardia is not publicly available.

Who are the main investors in StemCardia?

Investor information for StemCardia is not publicly disclosed.

Will StemCardia IPO soon?

No public IPO plans have been announced for StemCardia.

How can I track StemCardia secondary market activity?

Caplight tracks bids, offers, and trades in StemCardia's shares on secondary markets.

Firmographic Details

HeadquartersSeattle, Washington
Year Founded2023
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?